TAYLOR ELY: Open Payments
NPI 1467928770 · NEW BRAUNFELS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$490 in 24 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $429 · 2025 $490
Food & beverage: $490
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 4 | $76 |
| PFIZER INC. | 4 | $73 |
| Abbott Laboratories | 3 | $49 |
| Otsuka America Pharmaceutical, Inc. | 2 | $44 |
| GlaxoSmithKline, LLC. | 2 | $44 |
| ABBVIE INC. | 2 | $40 |
| Edwards Lifesciences Corporation | 1 | $38 |
| Axsome Therapeutics, Inc. | 1 | $31 |
| AstraZeneca Pharmaceuticals LP | 1 | $26 |
| Novo Nordisk Inc | 1 | $26 |
Products named: NURTEC ODT, REXULTI, EVENITY, SAPIEN 3 Ultra RESILIA, FREESTYLE LIBRE 3, Symbravo, BREZTRI, QULIPTA.
Industry payments across TX — which companies pay providers there.
